Furthermore, mitochondrial O-GlcNAc modification has been shown to enhance the therapeutic efficacy of transplanted mitochondria in a mouse model of stroke, while higher levels of O-GlcNAcylation in mitochondria correlating with improved clinical outcomes in SAH patients [177]
In a phase 2 trial funded by Amgen, people lost 20% of their body weight on average after a year of the injections and didnt reach a weight-loss plateau, meaning they could slim down more
It represents an emerging research compound in metabolic studies
Medicine 45 , 622628 (2017)
It stimulates the release of growth hormone from your own pituitary gland, which can support better sleep, improved muscle growth, fat loss, and improved energy
Although first explored in ASD more than a decade ago, it is not yet widely available